Introduction
The cardiovascular benefits of exercise are well established and epidemiological studies suggest that long term exercise programmes reduce the development of atheroma and the risk of sudden cardiac death (SCD).'-' It is well recognised that a very small but significant proportion of athletes may die suddenly. The precise incidence of SCD in young athletes is unknown but estimates from the United States suggest that it is very low. Such tragedies are highly publicised, particularly when high profile athletes are involved, causing major concern in the general community who perceive athletes as the most healthy segment of society. 6 The sudden and unexpected death of athletes has evoked considerable interest among doctors and pathologists and led to the detection of a wide number of cardiovascular disorders causing sudden death in this population.7 '7 Most non-traumatic sudden deaths in young athletes are due to inherited structural and functional cardiovascular abnormalities. Hypertrophic cardiomyopathy (HCM) accounts for 40-50% of all such deaths. Other well recognised causes include arrhythmogenic right ventricular cardiomyopathy, congenital anomalous coronary arteries, premature coronary artery disease, Wolff-ParkinsonWhite syndrome, long QT syndrome, myocarditis, and Marfan's syndrome (table 1) . Early identification of affected individuals should prevent sudden death. There is controversy about the extent of the problem, the significance of cardiovascular abnormalities detected at postmortem examination in athletes, and whether or not exercise related sudden death in apparently healthy individuals should be a cause for alarm in the sporting community. '8 Definitions Before proceeding further, it is prudent to define the terms "young", "competitive athlete", and "sudden cardiac death". Sporting individuals aged below 25 years will be classified as young. Although a substantial proportion of the population consider themselves to be athletes, we consider a competitive athlete as an individual who participates in an organised team or individual sport in which regular competition is a component.'9 SCD is defined as an event that is non-traumatic, nonviolent, unexpected, and resulting from sudden cardiac arrest within six hours of previously witnessed normal health.
SCD in young athletes is thought to be uncommon, but precise data on its exact incidence are lacking. Estimates from the United States suggest an incidence of 1 in 200 000.2>22 This is unlikely to represent the true incidence of SCD for several reasons. When faced with SCD in a young athlete, the coroner's mandate is to exclude foul play rather than provide the cause of death. An expert pathologist with experience of conditions causing SCD is rarely responsible for carrying out postmortem examination, thus subtle conditions may not be detected. The cause of death is difficult to ascertain in conditions predisposing to fatal cardiac arrhythmias, and SCD in the absence of structural cardiac abnormalities, for example, the long QT syndrome. Furthermore, the evident lack of a systematic national registry for SCD in athletes means that the compilation of statistics on SCD relies heavily upon reports from the media, which usually concentrate qn the most elite athletes rather than the general young athletic population, and on voluntary referrals from hospital based pathology registries. Such crude methods of data collection undoubtedly lead to a significant underestimation of exercise related SCDs.
Some 80% of non-traumatic sudden deaths in young competitive athletes are due to inherited/congenital structural or functional cardiovascular abnormalities, most of which provide a pathological substrate for fatal cardiac arrhythmias predisposing to sudden death. A proportion of affected athletes are capable of incredibly high levels of performance, and reports on the sudden deaths of athletes have shown that many had competed at intercollegiate, professional, and national level (table 2) .
The majority of deaths occur during or immediately after strenuous physical activity, suggesting that exercise is a strong trigger factor for cardiac arrhythmias in athletes harbouring potentially lethal cardiac conditions. Most deaths occur in men. This may be due to a higher participation rate and competition in reliance is placed on this investigation alone, then there is a risk of generating false positives and false negatives. Additional information from family history and the 12 lead electrocardiograph may be helpful in these circumstances. The demonstration of HCM in a first degree relative of an athlete with left ventricular hypertrophy will increase the possibility of the diagnosis of HCM. Voltage criteria of left ventricular hypertrophy and ST segment repolarisation changes on the electrocardiogram (ECG) are common in both conditions; however, the presence of prominent Q waves, left bundle branch block, and deep T wave inversion favours the diagnosis of HCM. Despite the ECG criteria, there are cases where differentiation of the normal athlete's heart from HCM remains difficult. A definitive method of resolving the diagnosis is demonstration of regression of ventricular hypertrophy after a three month period of detraining, a feature characteristic of physiological but not pathological hypertrophy."0 This is usually unacceptable to the athlete striving to achieve honours in competitive sport because it hinders fitness and team selection, but may be feasible during injury or in the off season. Future developments in molecular genetics should allow DNA testing in all individuals with suspected HCM. In the meantime, the development of more specific and sensitive cardiac tests for differentiating between physiological and pathological hypertrophy may obviate the need to detrain.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) ARVC is a heart muscle disorder characterised by patchy fibrofatty replacement of right ventricular myocardium. The replacement of myocardium by fatty tissue predisposes to inhomogeneous and fatal re-entrant ventricular arrhythmias.5' It is the commonest cause of exercise related SCD in young athletes in the Veneto region of northern Italy.52-54 The strong association with strenuous physical activity incriminates exercise as a trigger factor for arrhythmias. The exact incidence and prevalence are unknown, but the prevalence is estimated to be 1 in 10 Most deaths are related to strenuous physical activity. Myocardial inflammation with lymphocytic infiltration and focal necrosis shown at postmortem examination may be the substrate for exercise induced arrhythmias. Symptoms are non-specific, with coryzal symptoms or a mild febrile illness predominating the clinical picture. Specific signs include tachycardia, evidence of cardiomegaly, and rarely cardiac failure. The ECG information is non-specific but may show cardiac arrhythmias. In severe cases, there may be evidence of ventricular dilatation and impairment at echocardiography, but there are cases where the ECG is entirely normal,82 and therefore a high index of suspicion is required if deaths caused by myocarditis are to be prevented. All athletes with coryzal symptoms or a febrile illness should be rested until completely asymptomatic.
Marfan's syndrome Marfan's syndrome is an inherited connective tissue disorder characterised by skeletal, ocular, and cardiac abnormalities. The gene is located in the long arm of chromosome 15 and encodes the glycoprotein fibrillin (chromosome 15). The prevalence based on clinical criteria is 1 in 5000. Affected patients are excessively tall, have chest wall abnormalities, kyphoscoliosis, arachnodactyly, and high arched palates. Lens dislocation is common. Cardiac involvement is almost always characterised by mitral valve prolapse with or without mitral regurgitation. Aortic root dilatation is a potentially serious cardiac manifestation, and sudden death is usually from aortic dissection or rupture. There may be a family history of premature sudden death. Physical examination should raise suspicion of Marfan's syndrome. Patients should be referred for assessment of the aortic root by echocardiography. Prophylactic surgery is indicated once the aortic root diameter exceeds 6 cm. Abstinence from competitive sport and treatment with 3 blockers may retard aortic dilatation and prevent death from aortic rupture.
Mitral valve prolapse Mitral valve prolapse is extremely common in the general population. It is thought to affect up to 5% of the population. The condition is generally benign, but there are 60 cases of SCD in the medical literature thought to be associated with mitral valve prolapse. Only four deaths occurred in young individuals, and in only three of the 60 cases was death related to exercise." Symptoms include atypical sharp inframammary chest pain, fatigue, dizziness, and occasionally syncope. Mitral valve prolapse can be clinically detected by auscultation and confirmed by echocardiography. Controversy remains about its association with SCD. The detection of mitral valve prolapse after sudden death may be coincidental rather than causal, or it may be due to its association with Wolff-Parkinson-White syndrome or long QT syndrome. The approach to mitral valve prolapse in relation to participation in competitive sport should be pragmatic. In the absence of symptoms and signs and a positive family history of sudden death, full participation is allowed. It would be reasonable to disqualify athletes with a history of syncope, disabling chest pain, complex ventricular arrhythmias, significant mitral regurgitation, prolonged QT interval, Marfan's syndrome, and a family history of sudden death.
Screening and prevention of sudden death The incidence of cardiovascular conditions predisposing to SCD is low. SS is supported by a grant from the British Heart Foundation.
